SeqWell: Dan Calvo

SeqWell, a Beverly, Massachusetts-based provider of next-generation sequencing library construction technologies, has named appointed Dan Calvo as president and CEO, effective April 19. Calvo most recently served as president and and CEO of Gyros Protein Technologies from 2013 through its acquisition by Mesa Labs in 2019. Prior to that, he was president and CEO of Oncimmune from 2009 to 2013. Calvo also previously served as CEO at Cellomics and Assay Designs, through their acquisitions by Fisher Scientific an Enzo Biochem, respectively.